Nano-X Imaging grants legal chief 28,283 stock units
The chief legal officer's award is subject to continuous employment and vests in four equal 25% installments on dates from February 13, 2027, through August 13, 2028.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nano-X Imaging Ltd. granted Chief Legal Officer Feler Marina Gofman 28,283 restricted share units on October 13, 2026, under its 2019 Equity Incentive Plan. The units vest and settle for ordinary shares in four equal semi-annual installments of 25% each, on February 13, 2027, August 13, 2027, February 13, 2028, and August 13, 2028, subject in each case to her continuous employment. Separate informational holdings list direct options covering 15,000, 10,000, and 30,000 ordinary shares.
Insider Trade Summary
Grant/Award: 28,283 shares
Grant/Award
6 txns
Insider
Gofman Feler Marina
Role
Chief Legal Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares F1, F2 | 28,283 | $0.00 | $0.00 |
| holding | Stock Option (right to buy ordinary shares) F3, F5 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F3, F6 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F3, F7 | -- | -- | -- |
| holding | Ordinary Shares F3 | -- | -- | -- |
| holding | Ordinary Shares F3, F4 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 74,599 shares (Direct);
Stock Option (right to buy ordinary shares) — 55,000 contracts (Direct)
Footnotes (7)
- F1. The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 28,283 ordinary shares represented by 28,283 restricted share units ("RSUs"), pursuant to the Issuer's 2019 Equity Incentive Plan.
- F2. The 28,283 RSUs reported in this row vest and settle for underlying ordinary shares in four equal semi-annual installments of 25% each following the vesting commencement date of August 13, 2026--on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028-- subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date, such that by the two-year anniversary of the vesting commencement date (August 13, 2028), all underlying shares will be issued to the Reporting Person.
- F3. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on February 5, 2026, of which 50% vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (February 5, 2027) and the remaining 50% on the 24-month anniversary of the grant date (February 5, 2028).
- F5. The options reported in this row were granted to the Reporting Person by the Issuer on November 7, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (November 7, 2026).
- F6. The options reported in this row were granted to the Reporting Person by the Issuer on April 28, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (April 28, 2027).
- F7. The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027).
Key Figures
Restricted share units granted: 28,283 restricted share units
RSU vesting schedule: 4 equal installments of 25% each
Ordinary shares underlying options: 15,000 shares
+2 more
5 metrics
Restricted share units granted
28,283 restricted share units
Grant reported October 13, 2026
RSU vesting schedule
4 equal installments of 25% each
Vesting dates: February 13, 2027; August 13, 2027; February 13, 2028; and August 13, 2028
Ordinary shares underlying options
15,000 shares
Exercise price $17.63; expiration November 7, 2032
Ordinary shares underlying options
10,000 shares
Exercise price $17.63; expiration April 28, 2033
Ordinary shares underlying options
30,000 shares
Exercise price $11.52; expiration May 23, 2033
Key Terms
restricted share units, semi-annual installments, vesting commencement date, 2019 Equity Incentive Plan, +1 more
5 terms
semi-annual installments technical
"four equal semi-annual installments of 25% each"
vesting commencement date technical
"following the vesting commencement date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
2019 Equity Incentive Plan technical
"pursuant to the Issuer's 2019 Equity Incentive Plan"
exercise price financial
"exercise price $17.63"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many RSUs did NNOX grant its chief legal officer?
Nano-X Imaging Ltd. granted Chief Legal Officer Feler Marina Gofman 28,283 restricted share units on October 13, 2026, under its 2019 Equity Incentive Plan.
What stock options are listed for NNOX's Feler Marina Gofman?
The listed direct option holdings cover 15,000 ordinary shares at an exercise price of $17.63, expiring November 7, 2032; 10,000 at $17.63, expiring April 28, 2033; and 30,000 at $11.52, expiring May 23, 2033.
AI-generated analysis. How Rhea-AI works. Not financial advice.
